Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8252 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8163 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8163 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8163 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8143 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8143 |
Intermediate Similarity |
NPD943 |
Approved |
0.8069 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8042 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8042 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8028 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7919 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7877 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7852 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7843 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7836 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7832 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7823 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.782 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7808 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7808 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7756 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7752 |
Intermediate Similarity |
NPD74 |
Approved |
0.7752 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7742 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7697 |
Intermediate Similarity |
NPD920 |
Approved |
0.7692 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7681 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7674 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7674 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7674 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7662 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7647 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7643 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7619 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7619 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7619 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7619 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7593 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7554 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7551 |
Intermediate Similarity |
NPD3748 |
Approved |
0.755 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7518 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7439 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7364 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7358 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7357 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7351 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7343 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7312 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7289 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7287 |
Intermediate Similarity |
NPD940 |
Approved |
0.7287 |
Intermediate Similarity |
NPD846 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7261 |
Intermediate Similarity |
NPD3226 |
Approved |
0.726 |
Intermediate Similarity |
NPD3268 |
Approved |
0.726 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.723 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7222 |
Intermediate Similarity |
NPD919 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD4287 |
Approved |
0.716 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7143 |
Intermediate Similarity |
NPD411 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD520 |
Approved |
0.7086 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7037 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7018 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD2403 |
Approved |
0.6993 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD7054 |
Approved |
0.6982 |
Remote Similarity |
NPD6020 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6944 |
Remote Similarity |
NPD3972 |
Approved |
0.6943 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD7472 |
Approved |
0.6937 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6933 |
Remote Similarity |
NPD4288 |
Approved |
0.6928 |
Remote Similarity |
NPD1247 |
Approved |
0.6923 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD3267 |
Approved |
0.6918 |
Remote Similarity |
NPD3266 |
Approved |
0.6913 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6887 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6887 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6886 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6883 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6883 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6883 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6883 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6863 |
Remote Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.6861 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6859 |
Remote Similarity |
NPD7003 |
Approved |
0.6857 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6853 |
Remote Similarity |
NPD2932 |
Approved |
0.6853 |
Remote Similarity |
NPD17 |
Approved |
0.6853 |
Remote Similarity |
NPD3019 |
Approved |
0.6849 |
Remote Similarity |
NPD1876 |
Approved |
0.6842 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6826 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.681 |
Remote Similarity |
NPD37 |
Approved |
0.6807 |
Remote Similarity |
NPD6234 |
Discontinued |
0.68 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6788 |
Remote Similarity |
NPD4965 |
Approved |
0.6788 |
Remote Similarity |
NPD4966 |
Approved |
0.6786 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD4749 |
Approved |
0.6778 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6778 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6776 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6759 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6755 |
Remote Similarity |
NPD6663 |
Approved |
0.6752 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6748 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6742 |
Remote Similarity |
NPD3020 |
Approved |
0.6735 |
Remote Similarity |
NPD3225 |
Approved |
0.6727 |
Remote Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD1929 |
Approved |
0.6716
|
Remote Similarity |
NPD1930 |
Approved |